 | Verve Therapeutics, Inc. | |||
| NMS : VERV || Location: United States | ||||
$6.67+0.01 (+0.15%) |
0.28 M | 6.5 - 6.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 15.358 M |
| March 15, 2024 | 14.105 M |
| Feb. 29, 2024 | 12.521 M |
| Feb. 15, 2024 | 12.587 M |
| Jan. 31, 2024 | 12.374 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.84 | -0.69 | 17.70% |
| 09/30/2023 | -0.94 | -0.72 | 23.11% |
| 06/30/2023 | -0.94 | -0.87 | 7.09% |
| 03/31/2023 | -0.79 | -0.84 | -5.71% |
| 12/31/2022 | -0.78 | -0.67 | 14.10% |
VERV Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 83.619M | Shares Float | 66.879M |
| Short Float | 15.358M | Market Cap | 556.90M |
| Institution ownership | 88.06% | Insider ownership | 7.649% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.12 | Forward EPS | -3.10 |